GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSTO:AKBMo) » Definitions » Research & Development

Aker BioMarine ASA (OSTO:AKBMO) Research & Development : kr0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aker BioMarine ASA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aker BioMarine ASA's Research & Development for the three months ended in Sep. 2024 was kr0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was kr0 Mil.


Aker BioMarine ASA Research & Development Historical Data

The historical data trend for Aker BioMarine ASA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Research & Development Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.77 34.00 26.94 39.52 4.22

Aker BioMarine ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aker BioMarine ASA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA  (OSTO:AKBMo) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Aker BioMarine ASA Research & Development Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA Headlines

No Headlines